Example: Heart Attack

Search clinical trials for: decrease of sedation doses and switch of ventilator settings

Total 10000 results

NCT01198535

Terminated

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Recurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal Cancer | Colon Mucinous Adenocarcinoma | Colon Signet Ring Cell Adenocarcinoma | Rectal Mucinous Adenocarcinoma | Rectal Signet Ring Cell Adenocarcinoma
NCT00721331

Completed

A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers

Atopic Dermatitis
NCT01376882

Completed

Cognitive and Cerebral Blood Flow Effects of 2-week Caffeine Abstinence or Maintenance

Cognitive Function | Mood | Caffeine Withdrawal | Cerebral Haemodynamics
NCT01416038

Completed

Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer
NCT01734941

Terminated

TSO in Pediatric Autistic Spectrum Disorders (TSO)

Autistic Spectrum Disorders
NCT00117520

Completed

The Effect of Caffeine in Elderly Citizens

Healthy Elderly Citizens
NCT00593866

Completed

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

Pancreatic Cancer
NCT02756728

Terminated

A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma

Multiple Myeloma
NCT01396148

Completed

A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumors
NCT01100268

Completed

Enhancing Attention in Adults With Compulsive Hoarding

Hoarding Disorder
NCT01131468

Completed

Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine

Drug-induced Ototoxicity in Peritoneal Dialysis Patients
NCT05281562

Terminated

Immunonutrition for Diabetic Foot Ulcers

Diabetes Mellitus | Diabetic Foot Ulcer | Diabetic Peripheral Neuropathy
NCT06184685

Completed

Safety and Efficacy of Sahasthara ME vs Diclofenac ME for Treating Primary Knee Osteoarthritis

Primary Knee Osteoarthritis
NCT01447069

Unknown

Use of Beta-agonists in Stable Severe Congestive Heart Failure

Heart Failure | Ischemic Cardiomyopathy | Non-ischemic Cardiomyopathy
NCT06537297

Not yet recruiting

Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases

Non-small Cell Lung Cancer
NCT04226690

Completed

Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products

Pain
NCT04841018

Completed

Does Low Dose of Dexamethasone Enhance Analgesic Quality of Caudal Analgesia in Children Undergoing Orchiopexy?

Patients With Cryptorchism Who Are Planning to Undergo Orchiopexy
NCT00588523

Completed

Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma

CNS Cancer | CNS BRAIN
NCT07118839

Recruiting

MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder (MAP VETS)

Post Traumatic Stress Disorder | Alcohol Use Disorder
NCT01365195

Terminated

Effect of Ketamine on Postoperative Clinical Outcomes

Colorectal Surgery
NCT03492047

Completed

N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients

Peripheral Neuropathy Due to Chemotherapy
NCT01124552

Completed

A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet
NCT03475121

Completed

Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma (RbGALOP2)

Unilateral Retinoblastoma
NCT01585558

Completed

Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

Atrophy | Vaginal Diseases
NCT02311608

Unknown

Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails (CER:T)

Liver Cirrhosis | Hemorrhage | Esophageal and Gastric Varices
NCT02136784

Unknown

Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals

Analgesic Response
NCT03950817

Completed

Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute Pain in the Pediatric ED

Pain
NCT02426099

Completed

Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension (SPIRY)

Diabetes Mellitus | Hypertension, Resistant to Conventional Therapy
NCT00834925

Unknown

Low Dose of Diltiazem for Rate Control of Atrial Fibrillation

Atrial Fibrillation
NCT04908111

Suspended

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Non-small Cell Lung Cancer (NSCLC) | Squamous Oesophageal Cancer
NCT01610401

Completed

The Metformin-FMD Trial (MetFMD)

Ischemia Reperfusion Injury | Endothelial Function
NCT07035002

Recruiting

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Colorectal Cancer (CRC) | PD-1 | Tumor Infiltrating Lymphocytes
NCT02643381

Completed

Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial (EvK)

Respiratory Arrest | Cardiopulmonary Arrest
NCT05158075

Completed

Program for the Comprehensive Neurocognitive Treatment of Excess Weight (TRAINEP)

Obesity | Overweight
NCT03768778

Completed

Non-missile Penetrating Head Trauma,Cases Registry in Sohag University Hospital (trauma)

Head Injuries With Non Missile Penetrating Objjects
NCT06948136

Recruiting

Acute Effects of THC in Older Adult (THC-Aging)

Age-related Cognitive Decline
NCT06575179

Recruiting

Dexmedetomidine Reduces Sevoflurane MAC-BAR During Pneumoperitoneum

Laparoscopic Cholecystectomy
NCT06058702

Recruiting

Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans

Schizophrenia | Cannabis Use Disorder
NCT02132897

Completed

Fed Bioequivalence Study of CBZ Formulations

Bio-equivalence Study | Fed Conditions
NCT04803162

Active, not recruiting

The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE

Eosinophilic Esophagitis
NCT06389422

Recruiting

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Hepatocellular Carcinoma | Radiotherapy | Pembrolizumab | Tumor Thrombosis
NCT04881032

Active, not recruiting

AGuIX Nanoparticles with Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma (NANO-GBM)

Glioblastoma
NCT02068196

Active, not recruiting

A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma. (Ipi4)

Malignant Melanoma
NCT04579133

Terminated

Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy

Bladder Cancer | Urothelial Carcinoma
NCT01280617

Completed

Low Dose Thymoglobin in Renal Transplant Patients

Acute Renal Failure
NCT03257995

Completed

Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.

Asthma
NCT02406170

Completed

Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma (REPEAT)

Stomach Neoplasms | Neoplasm Metastasis | Esophageal Neoplasms
NCT01717807

Unknown

C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). (EGFR; PET/CT)

Pancreatic Cancer | Lung Cancer
NCT03371849

Completed

PK and Safety Study of HCP1102, HGP0813 and HGP1408

Healthy
NCT06700720

Recruiting

YN001-004 in Patients With Coronary Atherosclerosis in Australia

Coronary Artery Disease | Coronary Atherosclerotic Disease

Search clinical trials for: decrease of sedation doses and switch of ventilator settings

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations